We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
(-19%)
Cap. Flow
-$3.3B
Cap. Flow
% of AUM
-4.75%
Top 10 Holdings %
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$753M |
| 2 |
Marathon Petroleum
MPC
|
+$374M |
| 3 |
Target
TGT
|
+$361M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$299M |
| 5 |
Huntington Bancshares
HBAN
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$1.05B |
| 2 |
Merck
MRK
|
+$702M |
| 3 |
Bank of America
BAC
|
+$542M |
| 4 |
Oracle
ORCL
|
+$528M |
| 5 |
Steel Dynamics
STLD
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.74% |
| 2 | Healthcare | 14.95% |
| 3 | Industrials | 13.38% |
| 4 | Technology | 12.24% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
176
Novo Nordisk
NVO
$203B
| $100M | 0.14% |
+4,339,664
| New | +$96.4M |
|
177
Sony
SONY
$146B
| $97.5M | 0.14% |
10,093,700
+3,014,615
| +43% | +$31.9M |
|
178
Tyson Foods
TSN
$19.5B
| $96.5M | 0.14% |
+1,807,842
| New | +$106M |
|
179
Moody's
MCO
$89.3B
| $95.5M | 0.14% |
682,036
-227,393
| -25% | -$34.3M |
|
180
Huntington Ingalls Industries
HII
$11.5B
| $94.9M | 0.14% |
498,408
+14,416
| +3% | +$3.14M |
|
181
Caterpillar
CAT
$371B
| $93.8M | 0.13% |
738,367
+563,996
| +323% | +$73.4M |
|
|
SPR
182
DELISTED
Spirit AeroSystems
SPR
| $93.4M | 0.13% |
1,295,589
-184,248
| -12% | -$14.9M |
|
183
Navient
NAVI
$896M
| $92.9M | 0.13% |
10,540,983
-5,411,366
| -34% | -$62M |
|
184
Belden
BDC
$4.52B
| $90.1M | 0.13% |
2,155,982
-1,804,156
| -46% | -$98.2M |
|
185
Melco Resorts & Entertainment
MLCO
$2.01B
| $87.6M | 0.13% |
4,969,419
+4,307,173
| +650% | +$76.8M |
|
186
DuPont de Nemours
DD
$18.5B
| $86.7M | 0.12% |
640,082
+26,005
| +4% | +$3.73M |
|
|
BERY
187
DELISTED
Berry Global Group, Inc.
BERY
| $86.5M | 0.12% |
1,981,195
-301,834
| -13% | -$12.9M |
|
|
TWO
188
DELISTED
Two Harbors Investment
TWO
| $86.2M | 0.12% |
1,679,076
+104,176
| +7% | +$5.94M |
|
189
Hasbro
HAS
$13.4B
| $85.4M | 0.12% |
1,051,161
+147,307
| +16% | +$13.7M |
|
190
Crown Holdings
CCK
$12.8B
| $84.6M | 0.12% |
2,035,859
-1,323,286
| -39% | -$61.2M |
|
191
American Electric Power
AEP
$66.8B
| $83.5M | 0.12% |
1,116,712
+369,815
| +50% | +$27.7M |
|
|
ATVI
192
DELISTED
Activision Blizzard
ATVI
| $82.5M | 0.12% |
1,770,566
+240,389
| +16% | +$14.4M |
|
|
RPAI
193
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $81.7M | 0.12% |
7,533,107
+2,252,191
| +43% | +$26.9M |
|
194
Ross Stores
ROST
$73.5B
| $80.8M | 0.12% |
+970,681
| New | +$87.9M |
|
195
Canadian Natural Resources
CNQ
$101B
| $80.6M | 0.12% |
6,824,117
+6,534,143
| +2,253% | +$87.8M |
|
196
American Homes 4 Rent
AMH
$12.1B
| $79.5M | 0.11% |
4,006,158
+104,066
| +3% | +$2.13M |
|
197
Jabil
JBL
$32.2B
| $79M | 0.11% |
3,188,155
-112,785
| -3% | -$2.75M |
|
198
Altria Group
MO
$114B
| $79M | 0.11% |
1,598,927
+416,826
| +35% | +$24.2M |
|
|
AGN
199
DELISTED
Allergan plc
AGN
| $77.3M | 0.11% |
578,328
+559,045
| +2,899% | +$91.6M |
|
200
Boston Scientific
BSX
$68B
| $75.2M | 0.11% |
2,128,475
+55,808
| +3% | +$2.02M |
|
Similar funds
Boston Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.
- Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
- Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
- Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
- Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
- Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
- Boston Partners opened 83 new positions and closed 76 in Q4 2018.
- Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.
Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.